Personalis Hopes to Increase Diagnostic Yield with 'Enhanced' Clinical Exome; Shows Pilot Data | GenomeWeb

Personalis has launched an early-access program for its "Accuracy and Content Enhanced," or ACE, Clinical Exome test to diagnose rare Mendelian disorders, which it hopes will increase the diagnostic yield of conventional diagnostic exome sequencing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.